SEARCH

SEARCH BY CITATION

References

  • 1
    Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 82741.
  • 2
    Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83: 1829.
  • 3
    Statistics and Information Department, Minister's Secretariat, Ministry of Health, Labour and Welfare. Vital Statistics of Japan 1950–2003. Tokyo: Health and Welfare Statistics Association, 19522005.
  • 4
    ESMO Guidelines Task Force. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC). Ann Oncol 2001; 12: 104950.
  • 5
    Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 171017.
  • 6
    Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer. Chest 2002; 122: 103757.
  • 7
    Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Impact of comorbidity on lung cancer survival. Int J Cancer 2003; 103: 792802.
  • 8
    Levy S, Herberman R, Lippman M, D’Angelo T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol 1987; 5: 34853.
  • 9
    Pettingale KW, Philalithis A, Tee DE, Greer HS. The biological correlates of psychological responses to breast cancer. J Psychosom Res 1981; 25: 4538.
  • 10
    Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000; 92: 9941000.
  • 11
    Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. JAMA 1979; 242: 15048.
  • 12
    Ratcliffe MA, Dawson AA, Walker LG. Eysenck Personality Inventory 1-scores in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Psychooncology 1995; 4: 3945.
  • 13
    Schulz R, Bookwala Knapp J, Scheier M, Williamson G. Pessimism, age, and cancer mortality. Psychol Aging 1996; 11: 3049.
  • 14
    Ringdal GI, Gotestam KG, Kaasa S, Kvinnsland S, Ringdal K. Prognostic factors and survival in a heterogeneous sample of cancer patients. Br J Cancer 1996; 73: 15949.
  • 15
    Buccheri G. Depressive reactions to lung cancer are common and often followed by a poor outcome. Eur Respir J 1998; 11: 1738.
  • 16
    Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999; 354: 13316.
  • 17
    Loberiza FR Jr, Rizzo D, Bredeson CN et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant distress. J Clin Oncol 2002; 20: 211826.
  • 18
    Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer 2002; 94: 271927.
  • 19
    Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jørgensen T. Depression as a prognostic factor for breast cancer mortality. Psychosomatics 2003; 44: 2430.
  • 20
    Brown KW, Levy AR, Rosberger Z, Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med 2003; 65: 63643.
  • 21
    Goodwin JS, Shang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 2004; 52: 10611.
  • 22
    Faller H, Schmidt M. Prognostic value of depressive coping and depression in survival of lung cancer patients. Psychooncology 2004; 13: 35963.
  • 23
    Faller H, Bülzebruck H, Drings P, Lang H. Coping, distress, and survival among patients with lung cancer. Arch General Psychiatry 1999; 56: 75662.
  • 24
    Cody M, Nichols Brennan C, Armes J, Wilson P, Slevin M. Psychosocial factors and lung cancer prognosis. Psychooncology 1994; 3: 141.
  • 25
    Uchitomi Y, Mikami I, Kugaya A et al. Depression after successful treatment for non-small cell lung carcinoma. Cancer 2000; 89: 11729.
  • 26
    Uchitomi Y, Mikami I, Nagai K, Nishiwaki Y, Akechi T, Okamura H. Depression and psychological distress in patients during the year after curative resection of non-small-cell lung cancer. J Clin Oncol 2003; 21: 6977.
  • 27
    Mountain CF. A new international staging system for lung cancer. Chest 1986; 89 (Suppl.): 225S233S.
  • 28
    Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R. Washington, DC: American Psychiatric Press, 1990.
  • 29
    Kathol RG, Mutgi A, Williams J, Clamon G, Noyes R Jr. Diagnosis of major depression in cancer patients according to four sets of criteria. Am J Psychiatry 1990; 147: 10214.
  • 30
    McNair D, Lorr M, Droppleman L. EITS Manual for the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service, 1971.
  • 31
    Yokoyama K, Araki S, Kawakami N, Takeshita T. Production of the Japanese edition of profile of mood states (POMS): assessment of reliability and validity. Jpn J Public Health 1990; 37: 91318.
  • 32
    Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, PA: Lippincott-Raven, 1998.
  • 33
    Okano Y, Okamura H, Watanabe T et al. Mental adjustment to first recurrence and correlated factors in patients with breast cancer. Breast Cancer Res Treat 2001; 67: 25562.
  • 34
    Maunsell E, Brisson J, Deschenes L. Social support and survival among women with breast cancer. Cancer 1995; 76: 6317.
  • 35
    Oken MM, Greech RH, Tormey DC et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 64955.